Related Experiment Video
Updated: Nov 22, 2025

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Effect of Ras-guanine nucleotide release factor 1-mediated H-Ras/ERK signaling pathway on glioma
Yi-Heng Pan1, Jing Chen1, Cui Sun1
1Center for Diagnosis and Treatment of Neuro-oncology Diseases, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.
Objective:
To investigate the function of Ras-guanine nucleotide release factor 1 (Ras-GRF1) in glioma through mediating H-Ras/ERK signaling pathway.
Methods:
Ras-GRF1, H-Ras, K-Ras and N-Ras expressions in glioma and normal brain tissues were detected via Immunohistochemistry. Glioma cells (U87 cells, U251 cells and primary human glioma cells) were transfected with Ras-GRF1 siRNA, H-Ras siRNA and/or Ras-GRF1 lentivirus activation particles. Then, the following aspects were evaluated: cell proliferation by MTT assay, clonogenic ability by the plate clone formation experiment, cell migration and invasion by Wound-healing and Transwell assays, and cell apoptosis by Annexin-V-FITC/PI staining. The protein expressions were measured by Western blotting. Subcutaneous and orthotopic mouse models of glioma were conducted to determine the role of Ras-GRF1 in glioma tumorigenesis.
Results:
Ras-GRF1, H-Ras, K-Ras and N-Ras expressions were upregulated in the glioma tissues, which were correlated with the WHO grade of glioma. Besides, Ras-GRF1 expression was positively related to H-Ras expression. Ras-GRF1 siRNA could reduce the expression of H-Ras and p-ERK/ERK in glioma cell. H-Ras siRNA inhibited the proliferation, clone formation, migration and invasion, and enhance the apoptosis of glioma cells, which, however, were reversed by Ras-GRF1 lentivirus activation particles. In vivo experiments also revealed that Ras-GRF1 shRNA reduced the volume and weight of the tumors in the nude mice, with down-regulations of H-Ras and p-ERK/ERK.
Conclusion:
Ras-GRF1 was upregulated in glioma tissues and correlated with its malignancy and prognosis. Silencing Ras-GRF1, through mediating H-Ras/ERK pathway, may suppress the growth and metastasis of glioma.
Insights
Ras-guanine nucleotide release factor 1 (Ras-GRF1) is upregulated in glioma and promotes tumor growth and metastasis by activating the H-Ras/ERK pathway. Silencing Ras-GRF1 may suppress glioma progression.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cell Signaling
Background:
- Glioma is a primary brain tumor with poor prognosis.
- The Ras-guanine nucleotide release factor 1 (Ras-GRF1) role in glioma remains unclear.
- Understanding signaling pathways involved in glioma is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the function of Ras-guanine nucleotide release factor 1 (Ras-GRF1) in glioma.
- To elucidate the role of Ras-GRF1 in mediating the H-Ras/ERK signaling pathway in glioma.
- To explore Ras-GRF1 as a potential therapeutic target for glioma.
Main Methods:
- Immunohistochemistry was used to detect Ras-GRF1, H-Ras, K-Ras, and N-Ras expression in glioma and normal brain tissues.
- Glioma cells were transfected with Ras-GRF1 siRNA, H-Ras siRNA, and Ras-GRF1 lentivirus.
- Cell proliferation, clonogenic ability, migration, invasion, and apoptosis were evaluated using MTT, plate clone formation, wound-healing, Transwell, and Annexin-V/PI assays, respectively.
- Western blotting measured protein expression, and in vivo studies utilized subcutaneous and orthotopic mouse models.
Main Results:
- Ras-GRF1, H-Ras, K-Ras, and N-Ras expressions were upregulated in glioma tissues and correlated with WHO grade.
- Ras-GRF1 expression positively correlated with H-Ras expression.
- Ras-GRF1 silencing reduced H-Ras and p-ERK/ERK expression, inhibiting glioma cell proliferation, clone formation, migration, and invasion while enhancing apoptosis.
- In vivo, Ras-GRF1 silencing reduced tumor volume and weight, with decreased H-Ras and p-ERK/ERK levels.
Conclusions:
- Ras-GRF1 is upregulated in glioma, correlating with malignancy and prognosis.
- Ras-GRF1 promotes glioma growth and metastasis by mediating the H-Ras/ERK pathway.
- Targeting Ras-GRF1 may represent a novel therapeutic strategy for glioma.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
GTPases and their Regulation
Large G-proteins,...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

